What are the recommended synchronized cardioversion energy levels for different arrhythmias such as sustained monomorphic ventricular tachycardia, atrial fibrillation, atrial flutter, and atrial tachycardia (AVNRT/AVRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Synchronized Cardioversion Energy Levels by Rhythm

For sustained monomorphic ventricular tachycardia (VT), start with 100 J; for atrial fibrillation use 120-200 J (biphasic); for atrial flutter and other SVTs (including AVNRT/AVRT) use 50-100 J initially, escalating in stepwise fashion if unsuccessful. 1

Sustained Monomorphic Ventricular Tachycardia (VT)

  • Initial energy: 100 J (both monophasic and biphasic waveforms) 1
  • If first shock fails, increase dose stepwise 1
  • This applies to regular VT with a pulse and hemodynamic stability or instability
  • Critical distinction: Polymorphic VT (like torsades de pointes) cannot be synchronized—treat as VF with high-energy unsynchronized shocks (defibrillation doses) 1, 2

Atrial Fibrillation (AF)

Biphasic Waveforms

  • Initial energy: 120-200 J (Class IIa, LOE A) 1
  • Research suggests optimizing based on duration:
    • AF ≤2 days: 100 J initial 3
    • AF >2 days: 150 J initial 3
  • Escalate stepwise if initial shock fails 1

Monophasic Waveforms

  • Initial energy: 200 J (Class IIa, LOE B) 1
  • Increase stepwise to 360 J if needed 4

Atrial Flutter and Other SVTs

  • Initial energy: 50-100 J 1
  • These rhythms generally require less energy than AF 1
  • Research specifically supports 50 J as optimal initial energy for atrial flutter/atrial tachycardia to minimize total cumulative energy 3
  • Escalate stepwise if 50 J fails 1
  • This applies to:
    • Atrial flutter
    • AVNRT (atrioventricular nodal reentrant tachycardia) 5
    • AVRT (atrioventricular reentrant tachycardia) 5
    • Other atrial tachycardias

Critical Clinical Considerations

Waveform Selection

  • Biphasic waveforms are superior to monophasic, achieving higher success rates at standard energy levels 4
  • For persistent AF, anteroposterior (AP) electrode placement with biphasic truncated exponential waveform at maximum energy shows highest efficacy 6

Hemodynamic Instability

  • Do not delay cardioversion if patient is extremely unstable 1
  • Establish IV access and provide sedation when possible, but hemodynamic compromise takes priority 1
  • For conscious but hypotensive patients, provide immediate sedation before cardioversion 2

Common Pitfalls to Avoid

  1. Automatic tachycardias are NOT responsive to cardioversion 1—these include:

    • Ectopic atrial tachycardia
    • Multifocal atrial tachycardia (MAT)
    • Junctional tachycardia
    • These require pharmacologic rate control, not electrical cardioversion
  2. Never attempt synchronized cardioversion on polymorphic VT—the irregular QRS prevents proper synchronization; use unsynchronized high-energy shocks instead 1, 2

  3. Ensure proper synchronization mode is activated—if synchronization fails or is impossible, use high-energy unsynchronized shocks (defibrillation doses) to avoid delivering shock during the vulnerable period 1

  4. Pre-excited atrial fibrillation requires immediate cardioversion if hemodynamically unstable, as rapid conduction through accessory pathway can degenerate to ventricular fibrillation 5

Escalation Strategy

When initial shock fails:

  • Increase energy in stepwise fashion 1
  • Consider antiarrhythmic drugs to enhance cardioversion success or prevent immediate recurrence 5, 2
  • For refractory cases, alternatives include dual defibrillators or internal cardioversion 4

Related Questions

In an adult patient with supraventricular tachycardia (SVT), when is cardioversion indicated and what are the recommended synchronized shock energy settings and sedation regimen?
What are the recommended drug dosages and electrical shock settings for cardioversion of atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation?
What is the recommended energy level for cardioversion (cardioversion is a medical procedure that uses electrical shocks to convert an abnormal heart rhythm to a normal one) in a patient with a history of difficult-to-convert arrhythmias or previous unsuccessful cardioversion attempts, considering starting at 100-150 Joules and potentially increasing to 250 Joules?
What are the recommended joules for electrical cardioversion in adults for atrial fibrillation, atrial flutter, and other supraventricular tachyarrhythmias?
What is the initial energy setting for synchronized cardioversion in joules?
What is the brand name of the combined oral contraceptive containing norgestimate 0.25 mg and ethinyl estradiol 0.035 mg?
In a patient with chronic kidney disease stage 3B, is a metformin dose of 1000 mg twice daily safe or should it be reduced?
What is the clinical significance and appropriate management of a high-sensitivity troponin I level of 7 ng/L?
In a patient with chronic kidney disease stage 3b (eGFR ~30‑44 mL/min/1.73 m²) who is taking dapagliflozin 5 mg daily, should the dose be increased?
What is the recommended starting dose of duloxetine (Cymbalta) for adults, and how should the dose be adjusted for elderly patients or those with renal impairment?
In what setting does a patient receive intravenous iron therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.